KYORIN Pharmaceutical Co Ltd (Kyorin), formerly KYORIN Holdings Inc, manufactures, develops and commercializes pharmaceuticals including new ethical drugs, generic drugs and over-the-counter (OTC) drugs. The company offers diagnostics, reagents, intermediates, industrial chemicals and other products. Kyorin markets its products under Kipres, Mucodyne, Pentasa, Uritos, Ketas, Flutiform, Milton, Rubysta and other brands. It also provides solutions to medical professionals in infection-related fields. The company operates its business through its subsidiaries KYORIN Rimedio Co Ltd and KYORIN Pharmaceutical Group Facilities Co Ltd in Japan. Kyorin is headquartered in Chiyoda-Ku, Japan.
Headquarters
Japan
Address
15/16f, Ochanomizu Sorashiti, 4-6, Kanda Surugadai, Chiyoda-Ku, Tokyo, 101-8311
Website
www.kyorin-pharm.co.jp
Telephone
81 3 35254700
No of Employees
2,138
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4569 (TYO)
Revenue (2022)
$836.8M
7.3%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
20.1%
(2022 vs 2021)
Market Cap*
$756.2M
Net Profit Margin (2022)
XYZ
11.8%
(2022 vs 2021)
* As of and is in US$
KYORIN Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| OTC Drugs: | Subcontracted Drug Manufacturing | Cool One |
| Cool One Damming GX- Cough | Lasvic | |
| Cool One Nasal Spray- Stuffy Nose, Head Congestion, Sneeze and Running Nose | Beova | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | New Products/Services | In May, the company launched GeneSoC PCR Master Mix. |
| 2023 | Acquisitions/Mergers/Takeovers | In April, the company merged with KYORIN Pharmaceutical Co., Ltd. |
| 2023 | New Products/Services | In March, the company launched Ultra-high-speed real-time PCR device GeneSoC mini R. |
Competitor Comparison
| Key Parameters | KYORIN Pharmaceutical Co Ltd | Astellas Pharma Inc | Teijin Ltd | Santen Pharmaceutical Co Ltd | Nippon Shinyaku Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Chiyoda-Ku | Chuo-Ku | Chiyoda-Ku | Osaka-Shi | Kyoto-Shi |
| State/Province | Tokyo | Tokyo | Tokyo | Osaka | Kyoto |
| No. of Employees | 2,138 | 14,484 | 22,484 | 4,144 | 2,186 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Minoru Hogawa | Chairman | Executive Board | - | - |
| Yutaka Ogihara | President; Director; Chief Executive Officer | Executive Board | - | - |
| Michiro Onota | Executive Director | Executive Board | - | - |
| Yoh Ito | Senior Corporate Officer; Director | Executive Board | - | - |
| Shigeru Ogihara | Assistant Chief Executive Officer; Senior Managing Director | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward